July 31st 2025
Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Brain Imaging Helpful for Goals of Care Decisions in Patients With Cognitive Motor Dissociation
April 25th 2023The potential ethical implications for goals of care discussions between surrogate decision makers and health care providers concerning patients who reside in a state of cognitive motor dissociation were investigated in this new study from a team at Columbia University and New York Presbyterian Hospital.
Read More
Dr Raj Chovatiya on Optimizing Patient-Centered Care in Atopic Dermatitis
April 24th 2023By better understanding the nature of atopic dermatitis and its varying comorbidities, providers might be able to better predict patient outcomes, said Raj Chovatiya, MD, PhD, assistant professor of dermatology, Northwestern University Feinberg School of Medicine.
Read More
Pediatric Patients With FCD, LEAT Exhibit No Significant Changes in IQ, QOL After Surgery
April 22nd 2023The systematic review and meta-analysis showed no correlation between epilepsy surgery and intelligence quotient (IQ) or quality of life (QOL) among younger patients with facial cortical dysplasia (FCD) and long-term epilepsy-associated tumors (LEAT).
Read More
Dr Mitzi Joi Williams: CHIMES Data Fill Need for More Complete Picture of MS Diversity
April 21st 2023In several abstracts presented at this year's American Academy of Neurology Annual Meeting, Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic, explores multiple sclerosis–related outcomes in diverse patient populations.
Watch
Providers Need to Be Educated About How Conditions May Vary in Skin of Color, Says Dr Andrew Alexis
April 18th 2023Lack of knowledge about how skin conditions present on lightly pigmented skin has resulted in diagnostic delays, underassessment, and an impact on quality of life for patients with skin of color.
Read More
Dr Lee Norman on What to Consider in Value-Based Care Implementation
April 18th 2023Lee A. Norman, MD, MHS, MBA, who spoke at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health March 9, 2023, in Kansas City, Missouri, discusses the shift to value-based care.
Watch
Dr Sancy Leachman Discusses Tailoring Genetic Testing for Melanoma to the Patient
April 16th 2023Each patient needs to weigh the benefits and risks of genetic testing for melanoma and have someone who can take the time to explain everything, including insurance risks, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
Watch
Dr Eva Parker Outlines Why Climate Change Has a Greater Health Impact on Marginalized Communities
April 12th 2023Not only are Black and Brown communities, as well as neighborhoods with lower socioeconomic status, disproportionately impacted by climate change, but these communities are not as readily able to adapt to mitigate the impacts climate change has on health.
Watch
Higher Rates of Respiratory Support Needed in Patients Admitted With RSV
April 10th 2023Patients who were admitted to the hospital for respiratory syncytial virus (RSV) had a higher risk of a complex hospital course and had higher rates of respiratory support compared with patients admitted for influenza.
Read More
Patients With PAH Accrue Higher Costs, HRU, Regardless of Etiology
April 10th 2023Patients with pulmonary arterial hypertension (PAH) related to connective tissue disorders (CTDs) and patients with PAH related to another condition accrued higher costs and higher health care resource use (HRU) vs patients who had CTD without PH.
Read More
Atopic Dermatitis Treatment Is Still More Trial and Error Than Personalized: Dr Emma Guttman-Yassky
April 9th 2023While the future is bright with potential for personalized medicine to treat atopic dermatitis, current treatment is still more like trial and error, said Emma Guttman-Yassky, MD, PhD, FAAD, of the Icahn School of Medicine at Mount Sinai.
Watch
Dr Samyukta Mullangi Explains How Thyme Care Integrates SDOH When Personalizing Care Navigation
March 31st 2023Samyukta Mullangi, MD, MBA, oncology fellow at Memorial Sloan Kettering Cancer Center and incoming medical director at Thyme Care, spoke on how her organization’s tech platform incorporates social determinants of health (SDOH) in care navigation to ensure high quality care and treatment.
Watch
Prurigo Nodularis Improves Following Treatment With Dupilumab
March 30th 2023Despite the approval of dupilumab (Dupixent) in September 2022, there is an ongoing dearth of clinically effective treatments for prurigo nodularis, prompting the present investigation of the monoclonal antibody for the chronic inflammatory skin condition.
Read More
Dr Sancy Leachman Outlines a “Spectrum of Problems” Between Melanoma Detection and Treatment
March 30th 2023There is a “spectrum” of problems and obstacles in a patient’s way once melanoma has been detected before that patient sees the right physician and receives treatment, said Sancy Leachman, MD, PhD, professor and chair in the Department of Dermatology and director of the Melanoma Research Program at the Knight Cancer Institute at Oregon Health and Science University.
Watch